gvtcx

Neuromodulation Devices and Associated Products 2023

NHS Supply Chain Published 18 May 2023 Contracts Finder

key details

Value£392,000,000
Statuscomplete
Category (CPV) 33158210
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Deadline19 Jun 2023
Contract start18 Mar 2024
Contract end17 Mar 2028
Procedureopen
SME suitableYes
OCIDocds-b5fd17-1d706017-98dd-455f-a48b-92d64782abf3

Awards (23)

This procurement was awarded to 23 suppliers. Values shown are per-award; the notice total is £392,000,000.

SupplierValueDateStatus
Abbott Medical U.K. Ltd. shared £392,000,000 9 Nov 2023 active
Avanos Medical UK Limited shared £392,000,000 9 Nov 2023 active
Axonics Modulation Technologies UK Ltd shared £392,000,000 9 Nov 2023 active
Boston Scientific Ltd shared £392,000,000 9 Nov 2023 active
BVM MEDICAL LTD shared £392,000,000 9 Nov 2023 active
Charco Neurotech shared £392,000,000 9 Nov 2023 active
ElectroCore UK Ltd. shared £392,000,000 9 Nov 2023 active
Far From Surgical Solutions shared £392,000,000 9 Nov 2023 active
Flow Neuroscience shared £392,000,000 9 Nov 2023 active
Freedom Neuro BV shared £392,000,000 9 Nov 2023 active
Inomed Neurocare Limited shared £392,000,000 9 Nov 2023 active
Inspire Medical Systems shared £392,000,000 9 Nov 2023 active
LivaNova UK Limited shared £392,000,000 9 Nov 2023 active
Mainstay Medical; ReActiv8 shared £392,000,000 9 Nov 2023 active
Medtronic Limited shared £392,000,000 9 Nov 2023 active
Nevro Medical LTD / Nevro Corp. shared £392,000,000 9 Nov 2023 active
Nyxoah SA shared £392,000,000 9 Nov 2023 active
Optimus Medical Ltd shared £392,000,000 9 Nov 2023 active
P14 Medical ltd/TA Platform 14 shared £392,000,000 9 Nov 2023 active
PHAGENESIS LTD shared £392,000,000 9 Nov 2023 active
Polar Medical Ltd shared £392,000,000 9 Nov 2023 active
Precisis GmbH shared £392,000,000 9 Nov 2023 active
Saluda Medical shared £392,000,000 9 Nov 2023 active

description

Non-exclusive Framework Agreement (FAG) for the supply to the NHS Supply Chain customer base via the E-Direct Route. Product range to include, but not limited to stimulation of; Deep Brain, Spinal Cord, Sacral Nerve, Vagal Nerve, Dorsal Route Ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps, Dorsal Ramus Medial Branch nerve and other devices that provide nerve stimulation or pain management that meet the requirements of users and patients. The FAG will provide access to Neuromodulation Devices/Consumables that are associated with Neuromodulation procedures.

Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £92,000,000.00 the term of FAG, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the FAG. The estimated value over the total FAG term (including any extension options) is £392,000,000.00.

Additional information:

Located in attachments is a Daft version of the Framework Agreement

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

3 notices published against this procurement.

PublishedTypeRegimeNotice
23 Feb 2023 Planning (planning) · d513d494-8c8c-4202-8ad2-29342578010c-617842
18 May 2023 Tender (tender) · 89f9781c-7b9a-4f55-847a-200aa8f04e23-646122
24 Nov 2023 Award (award) · 9143740d-a822-4c52-8c0b-f5060095098d-701697

more from NHS Supply Chain

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.